Skip to content

DEVANTHINIC PHARMA

Active Risk: not assessed Private limited companyfounded 2014active for 11 yearsRue des Canadiens 24, 7180 SeneffeKBO/BCE: BE 0506.893.294 #3 company by total assets in Seneffe, Administrative and support services sector
Heads the group DEVANTHINIC PHARMA 15 companies
See the group
DEVANTHINIC PHARMA
Follow ReportCompare

Timeline

23 events since 2014

Deadline for the 2026 accounts: 31-07-2027

2026
Annual accounts 2025 filed NBBabbreviated format · 27 days late
2025
Registered in the Peppol Directory Reachable for e-invoices through 0208:0506893294
Annual accounts 2024 filed PDFfull format · 29 days late
2024
Annual accounts 2023 filed PDFfull format · 26 days late
2023
Annual accounts 2022 filed PDFfull format · on the deadline day
2022
Highest result from 2015 to 2025 net €1.8m ▲113% The operating result of €970,758 and the net result of €1.8m are both a record.
Equity above €5m equity €5.2m ▲50.7% With a profit in every financial year since 2015, equity grows to €5.2m.
Annual accounts 2021 filed PDFfull format · 26 days late
2021
Appointment: ANDRÉ Anne Léa (statutory director)2 points ▸
  • Registered office clause, rue des Canadiens 24, 7180 Seneffe
  • Director appointment, ANDRÉ Anne Léa (statutory director)
  • The deed holds 8 more points.

Open the deed in the Belgian Official Gazette

Annual accounts 2020 filed PDFfull format · 30 days late
2020
Equity above €2m equity €2.6m ▲35.5% With a profit in every financial year since 2015, equity grows to €2.6m.
Annual accounts 2019 filed PDFmicro format · 87 days late
2019
Annual accounts 2018 filed PDFmicro format · 40 days late
2018
Equity above €1m equity €1.5m ▲461% With a profit in every financial year since 2015, equity grows to €1.5m.
Annual accounts 2017 filed PDFmicro format · 2 days late
Merger: DEVANTHINIC PHARMA takes over PHARMA-ZICancellation of 100 shares · The company holds all the shares of PHARMA-ZI · General meeting of 28-06-20184 points ▸
  • General meeting, 28-06-2018, mentioned twice in the deed
  • Accounting effect, 01-01-2018
  • The company holds all the shares of PHARMA-ZI
  • Power of attorney, Anne André (manager)
  • The deed holds 10 more points.

Open the deed in the Belgian Official Gazette

Merger proposal: DEVANTHINIC PHARMA takes over PHARMA-ZIThe company holds all the shares of PHARMA-ZI2 points ▸
  • Accounting effect, 01-01-2018
  • The company holds all the shares of PHARMA-ZI
  • The deed holds 4 more points.

Open the deed in the Belgian Official Gazette

2017
Permanent representative: De Vriese ThiblautBoard meeting of 30-09-20172 points ▸
  • Board meeting, 30-09-2017
  • Permanent representative, De Vriese Thiblaut, mentioned 4 times in the deed
  • The deed holds 1 more point.

Open the deed in the Belgian Official Gazette

Annual accounts 2016 filed PDFfull format · 8 days late
2016
Equity above €200,000 equity €207,372 ▲25.2% With a profit in every financial year since 2015, equity grows to €207,372.
Annual accounts 2015 filed PDFfull format · 17 days late
2014
First establishment Rue des Canadiens 24, Seneffe
Incorporation PDFpublished on 18-12-2014

Financial milestones sit on the financial year-end date, not the filing date.

Sources: Publications in the Belgian Official GazetteFilings with the National Bank

History

On 16 December 2014, DEVANTHINIC PHARMA was incorporated.1 PHARMA-ZI was merged into the company in 2018.2 Total assets went from €7.5m in 2018 to €16.8m in 2025 and headcount from 0.5 full-time equivalents in 2020 to 8.4 in 2025.3

  1. 1KBO register
  2. 2Belgian Official Gazette, 27-07-2018
  3. 3National Bank, annual accounts 2018, 2020 and 2025

Next steps

See this company's board, registered office and name on a given date.Company as of a date See what changed in the latest annual accounts.What changed

We would like to set cookies. That happens only with your consent. What we measure